Content area

|
|

Protonbehandling

Forfatter(e)
Hanna R. Mortensen1, 2, Morten Høyer2 & Cai Grau1, 2
1) Kræftafdelingen, Aarhus Universitetshospital2) Dansk Center for Partikelterapi, Aarhus Universitetshospital

Ugeskr Læger 2019;181:V04190243
Reference: 
Ugeskr Læger 2019;181:V04190243
Blad nummer: 

Hanna R. Mortensen, Morten Høyer & Cai Grau:

Proton therapy

Ugeskr Læger 2019;181:V04190243

This review summarises the potential usage of proton therapy in Denmark. About one third of Danes are diagnosed with cancer, and half of these need radiotherapy in the course of treatment. Radiation dose cannot be adequately increased without giving rise to unacceptable high risk of toxicity, but proton therapy is encouraging due to a unique depth dose distribution. In some cases, the benefit of proton therapy is obvious, but in most cases the gain is less obvious, and patients should only receive treatment within clinical trials. Clinical studies on proton therapy with focus on reduction of radiation-induced side effects and improvement of quality of life should be conducted.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Mads Aage Toft Kristensen | 16/11
1 Kommentar
af Ketil Bjerregård | 15/11
1 Kommentar
af Jens Lund Ahrenkiel | 15/11
1 Kommentar
af Nicolaj Markus Stilling | 15/11
2 kommentarer
af Marianne Puge Nielsen | 13/11
1 Kommentar
af Akil Raad Kami Abdel-Wahab Walli | 13/11
6 kommentarer
af Larry Højgaard Kristiansen | 11/11
1 Kommentar
af Sven Refslund Poulsen | 09/11
3 kommentarer